RICTOR Drives ZFX-mediated Ganglioside Biosynthesis to Promote Breast Cancer Progression.
K. Rajput, M. N. Ansari, S. K. Jha, N. Medatwal, P. Sharma, S. Datta, A. Kar, T. Pani, K. Cholke, K. Rana, A. Khan, G. Mukherjee, S. Deo, J. S. Prabhu, A. Mukhopadhyay, , U. Dasgupta
This study identifies RICTOR's role in regulating ganglioside biosynthesis via ZFX and UGCG, promoting breast cancer progression through EGFR signaling.
bioRxiv · Jan 10, 2022 · PreprintCancer Biology